• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性骨髓瘤患者参与多学科康复计划的健康相关生活质量。

Health-related quality of life in patients with multiple myeloma participating in a multidisciplinary rehabilitation program.

机构信息

Quality of Life Research Center, Department of Haematology, Odense University Hospital, Kløvervænget 10, 12. floor, 5000, Odense C, Denmark.

Department of Internal Medicine and Cardiology, Regional Hospital Viborg, Viborg, Denmark.

出版信息

Ann Hematol. 2021 Sep;100(9):2311-2323. doi: 10.1007/s00277-020-04356-0. Epub 2021 Jan 6.

DOI:10.1007/s00277-020-04356-0
PMID:33409622
Abstract

Patients with multiple myeloma (MM) report high symptom burden and functional disabilities resulting in impaired health-related quality of life (HRQoL). Effective evidence-based rehabilitation guidelines are needed for patients with MM to improve HRQoL. The primary aim of this study was to investigate HRQoL in patients with rehabilitation needs living their everyday life. Patients with MM in remission attended a 12-week multidisciplinary rehabilitation program including a 5-day residential course, home-based exercise and a 2-day follow-up course. The patients were referred by the treating haematologist and completed a booklet of validated HRQoL questionnaires at baseline and before arriving for the 2-day follow-up course. The proportion of participants with moderate to severe symptoms and functional problems were assessed at the two time points and multivariate logistic regression was used to investigate explaining factors of impaired HRQoL at baseline. Ninety-two patients participated with a follow-up compliance rate of 90%. Median age was 67 years and median time since diagnosis was 26 months (ranged 5 months to 15.6 years). The most frequently reported symptoms were global quality of life, role functioning, fatigue, pain, peripheral neuropathy and physical functioning. Pain and fatigue were both highly coherent with impairment in physical functioning and those two symptoms explained most HRQoL impairments. Overall, the participants reported no change in HRQoL after the 12-week rehabilitation program. The study supports the need for an evidence-based guideline for rehabilitation and palliative care to patients with MM in remission living their everyday life.

摘要

多发性骨髓瘤(MM)患者报告有较高的症状负担和功能障碍,导致健康相关生活质量(HRQoL)受损。需要为 MM 患者制定有效的循证康复指南,以提高 HRQoL。本研究的主要目的是调查日常生活中具有康复需求的 MM 患者的 HRQoL。缓解期的 MM 患者参加了为期 12 周的多学科康复计划,包括为期 5 天的住院课程、家庭运动和为期 2 天的随访课程。这些患者是由主治血液学家推荐的,并在基线和参加 2 天随访课程之前完成了一本经验证的 HRQoL 问卷手册。在这两个时间点评估了有中度至重度症状和功能问题的参与者的比例,并使用多变量逻辑回归来调查基线时 HRQoL 受损的解释因素。92 名患者参与了该研究,随访依从率为 90%。中位年龄为 67 岁,中位诊断后时间为 26 个月(范围为 5 个月至 15.6 年)。报告最频繁的症状是总体生活质量、角色功能、疲劳、疼痛、周围神经病变和身体功能。疼痛和疲劳均与身体功能障碍高度相关,这两个症状解释了大多数 HRQoL 受损的原因。总体而言,患者在 12 周康复计划后报告 HRQoL 没有变化。该研究支持为缓解期日常生活中的 MM 患者制定基于证据的康复和姑息治疗指南的必要性。

相似文献

1
Health-related quality of life in patients with multiple myeloma participating in a multidisciplinary rehabilitation program.多发性骨髓瘤患者参与多学科康复计划的健康相关生活质量。
Ann Hematol. 2021 Sep;100(9):2311-2323. doi: 10.1007/s00277-020-04356-0. Epub 2021 Jan 6.
2
The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study.疾病相关症状及姑息治疗问题对多发性骨髓瘤患者健康相关生活质量的影响:一项多中心研究
BMC Cancer. 2016 Jul 7;16:427. doi: 10.1186/s12885-016-2410-2.
3
Physical activity and health-related quality of life in multiple myeloma survivors: the PROFILES registry.多发性骨髓瘤幸存者的身体活动与健康相关生活质量:PROFILES 登记研究。
BMJ Support Palliat Care. 2020 Dec;10(4):e35. doi: 10.1136/bmjspcare-2018-001755. Epub 2019 Jun 28.
4
Living with advanced but stable multiple myeloma: a study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of life.患有晚期但稳定的多发性骨髓瘤:研究疾病的症状负担和累积效应以及强化(基于造血干细胞移植的)治疗对健康相关生活质量的影响。
J Pain Symptom Manage. 2013 Nov;46(5):671-80. doi: 10.1016/j.jpainsymman.2012.11.003. Epub 2013 Mar 25.
5
Patient-reported pain severity and health-related quality of life in patients with multiple myeloma in real world clinical practice.真实世界临床实践中多发性骨髓瘤患者的报告疼痛严重程度和健康相关生活质量。
Cancer Rep (Hoboken). 2022 Jan;5(1):e1429. doi: 10.1002/cnr2.1429. Epub 2021 Jun 10.
6
Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry.与正常人群相比,老年多发性骨髓瘤患者健康相关生活质量的恶化程度低于年轻患者:一项基于人群的PROFILES注册研究。
Ann Hematol. 2015 Apr;94(4):651-61. doi: 10.1007/s00277-014-2264-0. Epub 2014 Dec 5.
7
Exercise interventions on health-related quality of life for people with cancer during active treatment.积极治疗期间针对癌症患者健康相关生活质量的运动干预措施。
Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD008465. doi: 10.1002/14651858.CD008465.pub2.
8
The importance of physical function in patients with multiple myeloma for improving quality of life.多发性骨髓瘤患者的身体功能对提高生活质量的重要性。
Support Care Cancer. 2020 May;28(5):2361-2367. doi: 10.1007/s00520-019-05054-y. Epub 2019 Sep 5.
9
Longitudinal changes of health-related quality of life over 10 years in breast cancer patients treated with radiotherapy following breast-conserving surgery.保乳手术后接受放疗的乳腺癌患者 10 年健康相关生活质量的纵向变化。
Qual Life Res. 2023 Sep;32(9):2639-2652. doi: 10.1007/s11136-023-03408-y. Epub 2023 Apr 24.
10
The influence of baseline characteristics, treatment and depression on health-related quality of life in patients with multiple myeloma: a prospective observational study.基线特征、治疗和抑郁对多发性骨髓瘤患者健康相关生活质量的影响:一项前瞻性观察研究。
BMC Cancer. 2022 Oct 3;22(1):1032. doi: 10.1186/s12885-022-10101-9.

引用本文的文献

1
A Prognostic Symptom Model Incorporating Patient-Reported Symptoms for Transplant-Ineligible Patients with Multiple Myeloma.一种纳入患者报告症状的预后症状模型,用于不适宜移植的多发性骨髓瘤患者。
Cancers (Basel). 2025 Feb 1;17(3):489. doi: 10.3390/cancers17030489.
2
Novel Developments in the Treatment of Multiple Myeloma-Associated Bone Disease.多发性骨髓瘤相关骨病治疗的新进展
Cancers (Basel). 2023 Nov 25;15(23):5585. doi: 10.3390/cancers15235585.
3
The core symptom in multiple myeloma patients undergoing chemotherapy: a network analysis.

本文引用的文献

1
An Investigation of Occupational Therapists' and Physical Therapists' Perspectives on the Process of Change That Occurs among Clients during Rehabilitation, Including Their Use of Response Shift and Transformative Learning.职业治疗师和物理治疗师对康复过程中客户所发生的变化过程的看法调查,包括他们对反应转移和变革性学习的运用。
Physiother Can. 2019 Fall;71(4):355-366. doi: 10.3138/ptc-2018-0047.
2
Supervised and home-based physical exercise in patients newly diagnosed with multiple myeloma-a randomized controlled feasibility study.新诊断多发性骨髓瘤患者的监督式居家体育锻炼——一项随机对照可行性研究
Pilot Feasibility Stud. 2019 Nov 12;5:130. doi: 10.1186/s40814-019-0518-2. eCollection 2019.
3
化疗后多发性骨髓瘤患者的核心症状:网络分析。
Support Care Cancer. 2023 Apr 25;31(5):297. doi: 10.1007/s00520-023-07759-7.
4
The effect of exercise interventions on quality of life in patients with multiple myeloma: a systematic review and meta-analysis of randomised controlled trials.运动干预对多发性骨髓瘤患者生活质量的影响:一项随机对照试验的系统评价和荟萃分析
Clin Exp Med. 2023 Nov;23(7):3217-3230. doi: 10.1007/s10238-023-01058-5. Epub 2023 Apr 8.
5
Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study.患者报告结局在血液学复发或进展性疾病患者中的研究:一项纵向观察性研究。
Health Qual Life Outcomes. 2021 Nov 4;19(1):251. doi: 10.1186/s12955-021-01887-6.
6
Physical therapy for multiple myeloma patients with severely hindered daily living activities due to bone lesions: a report of two cases.针对因骨病变导致日常生活活动严重受限的多发性骨髓瘤患者的物理治疗:两例报告。
J Phys Ther Sci. 2021 Oct;33(10):795-800. doi: 10.1589/jpts.33.795. Epub 2021 Oct 13.
Quality of life in patients with relapsed/refractory multiple myeloma during ixazomib-thalidomide-dexamethasone induction and ixazomib maintenance therapy and comparison to the general population.
来那度胺-硼替佐米-地塞米松诱导及来那度胺维持治疗复发/难治性多发性骨髓瘤患者的生活质量及其与普通人群的比较。
Leuk Lymphoma. 2020 Feb;61(2):377-386. doi: 10.1080/10428194.2019.1666381. Epub 2019 Sep 26.
4
Relapsed refractory multiple myeloma: a comprehensive overview.复发难治性多发性骨髓瘤:全面概述。
Leukemia. 2019 Oct;33(10):2343-2357. doi: 10.1038/s41375-019-0561-2. Epub 2019 Aug 27.
5
Response shift effects in patients' assessments of their quality of life after cardiac rehabilitation.心脏康复后患者对生活质量评估的反应转移效应。
Qual Life Res. 2019 Sep;28(9):2609-2620. doi: 10.1007/s11136-019-02195-9. Epub 2019 May 8.
6
Symptoms and anxiety predict declining health-related quality of life in multiple myeloma: A prospective, multi-centre longitudinal study.症状和焦虑可预测多发性骨髓瘤患者健康相关生活质量的下降:一项前瞻性、多中心纵向研究。
Palliat Med. 2019 May;33(5):541-551. doi: 10.1177/0269216319833588.
7
The role of cement augmentation with percutaneous vertebroplasty and balloon kyphoplasty for the treatment of vertebral compression fractures in multiple myeloma: a consensus statement from the International Myeloma Working Group (IMWG).经皮椎体成形术和球囊椎体后凸成形术联合骨水泥强化治疗多发性骨髓瘤椎体压缩骨折的作用:国际骨髓瘤工作组(IMWG)的共识声明。
Blood Cancer J. 2019 Feb 26;9(3):27. doi: 10.1038/s41408-019-0187-7.
8
Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data.采用肿瘤临床联盟(Alliance)A151408 研究数据,对欧洲癌症研究与治疗组织(EORTC)生活质量问卷-化疗诱导性周围神经病(QLQ-CIPN20)进行基于 Rasch 模型的检验。
Support Care Cancer. 2019 Jul;27(7):2599-2608. doi: 10.1007/s00520-018-4553-y. Epub 2018 Nov 20.
9
In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials.寻找用于化疗引起的周围神经病变临床试验的金标准患者报告结局指标。
Cancer Control. 2018 Jan-Mar;25(1):1073274818756608. doi: 10.1177/1073274818756608.
10
The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study.合并症对多发性骨髓瘤死亡率的影响:一项基于丹麦全国人口的研究。
Cancer Med. 2017 Jul;6(7):1807-1816. doi: 10.1002/cam4.1128. Epub 2017 Jun 22.